HomeCompareCADE vs JNJ

CADE vs JNJ: Dividend Comparison 2026

CADE yields 3.43% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CADE wins by $34.3K in total portfolio value
10 years
CADE
CADE
● Live price
3.43%
Share price
$42.11
Annual div
$1.44
5Y div CAGR
31.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.8K
Annual income
$14,083.64
Full CADE calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — CADE vs JNJ

📍 CADE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCADEJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CADE + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CADE pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CADE
Annual income on $10K today (after 15% tax)
$291.42/yr
After 10yr DRIP, annual income (after tax)
$11,971.09/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, CADE beats the other by $7,933.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CADE + JNJ for your $10,000?

CADE: 50%JNJ: 50%
100% JNJ50/50100% CADE
Portfolio after 10yr
$47.6K
Annual income
$9,416.76/yr
Blended yield
19.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CADE
Analyst Ratings
1
Strong
6
Buy
13
Hold
Consensus: Hold
Price Target
$43.00
+2.1% upside vs current
Range: $40.00 — $47.00
Altman Z
-0.4
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CADE buys
4
JNJ buys
0
PoliticianChamberTickerTypeAmountDate
Neal P. Dunn🏢 House$CADE▼ Sell$1,001 - $15,0002026-02-02
Neal P. Dunn🏢 House$CADE▲ Buy$1,001 - $15,0002024-11-06
Neal P. Dunn🏢 House$CADE▲ Buy$1,001 - $15,0002024-09-27
Daniel Goldman🏢 House$CADE▼ Sell$1,001 - $15,0002023-07-12
Neal P. Dunn🏢 House$CADE▲ Buy$1,001 - $15,0002023-05-05
Daniel Goldman🏢 House$CADE▲ Buy$1,001 - $15,0002023-04-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCADEJNJ
Forward yield3.43%2.14%
Annual dividend / share$1.44$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR31.9%28%
Portfolio after 10y$64.8K$30.5K
Annual income after 10y$14,083.64$4,749.88
Total dividends collected$39.4K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$43.00$228.73

Year-by-year: CADE vs JNJ ($10,000, DRIP)

YearCADE PortfolioCADE Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,152$452.22$10,594$274.49+$558.00CADE
2$12,555$621.69$11,294$360.69+$1.3KCADE
3$14,296$862.73$12,133$476.91+$2.2KCADE
4$16,508$1,211.02$13,156$635.42+$3.4KCADE
5$19,387$1,723.80$14,432$854.61+$5.0KCADE
6$23,240$2,495.58$16,056$1,162.76+$7.2KCADE
7$28,554$3,687.67$18,175$1,604.53+$10.4KCADE
8$36,139$5,585.36$21,009$2,252.68+$15.1KCADE
9$47,382$8,713.85$24,911$3,229.73+$22.5KCADE
10$64,782$14,083.64$30,458$4,749.88+$34.3KCADE

CADE vs JNJ: Complete Analysis 2026

CADEStock

Cadence Bank provides commercial banking and financial services in the United States. Its products and services include consumer banking, consumer loans, mortgages, home equity lines and loans, credit cards, commercial and business banking, treasury management, specialized and asset-based lending, commercial real estate, equipment financing, and correspondent banking services. The company's products and services also comprise small business administration lending, foreign exchange, wealth management, investment and trust, financial planning, retirement plan management, and personal and business insurance services. As of March 3, 2022, it operated approximately 400 branch locations across the South, Midwest, and Texas. The company was incorporated in 1876 and is headquartered in Tupelo, Mississippi.

Full CADE Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CADE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CADE vs SCHDCADE vs JEPICADE vs OCADE vs KOCADE vs MAINCADE vs ABBVCADE vs MRKCADE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.